Lyve1-2A-CreERT2
Nomenclature
C57BL/6JSmo-Lyve1em2(2A-CreERT2)Smoc
Cat. NO.
NM-KI-250921
Strain State
Repository Live
Gene Summary
Gene Symbol
Lyve1
Model Description
鉴定报告
DownloadValidation Data
Fig1. Cre mediated recombination in liver of Lyve1CreERT2/+; Rosa26tdTomato/+ mouse.
Fig2. Detection of tdTomato(red) in various tissues of Lyve1CreERT2/+; Rosa26tdTomato/+ mouse.
After tamoxifen induction, tdTomato was expressed in the heart, lung, liver, stomach, salivary gland, adrenal gland, pancreas, large intestine, small intestine, ovary, muscle, skin, and vagina.
Tissues with low tdTomato expression: brain, spinal cord, brown adipose tissue, kidney, spleen, and thymus.
Tissues with no obvious expression: eyeball.(49-days old, female) (For more detailed information please contact our technical advisor.)
You may also like
Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn moreShanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreCustomizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
Learn more
